Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine
Paul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al. · 2008
Read Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine by Paul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002954.txt.
Description
Paul Makidon, Anna Bielinska, Shraddha Nigavekar and co-authors tested a new hepatitis B vaccine form in animals in 2008. Hepatitis B stays a major global health problem despite safe, effective vaccines. Current vaccines need cold storage and three shots, which restricts use where clinics are scarce.
Their candidate uses a nanoemulsion, a mix of tiny oil droplets, given through the nose as a mucosal vaccine. Pre-clinical evaluation means testing before human trials. Published in PLOS ONE, the work explores a form that could ease delivery in the developing world if later trials support it.
Catalog record
| CREATOR | Paul E. Makidon, Anna U. Bielinska, Shraddha S. Nigavekar et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 72 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002954